Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search), fold increases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search), fold increases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
2281
-
2282
-
2283
-
2284
Expression of proteins significantly correlated with stereotypy severity in CD1 Mice (n = 28).
Published 2025“…Expression of 7 proteins significantly correlated with stereotypy severity in CD1 mice. …”
-
2285
Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA.
Published 2025Subjects: -
2286
-
2287
-
2288
-
2289
-
2290
Amplitude for A/L = 0.29.
Published 2025“…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
-
2291
Amplitude for A/L = 0.338.
Published 2025“…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
-
2292
Amplitude for A/L = 0.02.
Published 2025“…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
-
2293
Amplitude for A/L = 0.03.
Published 2025“…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
-
2294
AUC of various models to predict imeglimin efficacy for liver function evaluated by ROC curves.
Published 2025Subjects: -
2295
-
2296
Comparison in baseline variables between efficacy group and non-efficacy group.
Published 2025Subjects: -
2297
-
2298
-
2299
Table 1_Dual variants of uncertain significance in a case of hyper-IgM syndrome: implications for diagnosis and management.docx
Published 2025“…Background<p>Hyper-IgM syndrome (HIGM) is a genetic immunodeficiency characterized by elevated to normal IgM levels and decreased IgG, IgA, and IgE. …”
-
2300